Synthetic dna vectors and methods of use
AssigneeIntergalactic Therapeutics, Inc.
InventorsBruce C. Schnepp, Philip R. Johnson
Life of this patent
Estimating the term…
Loading patent…
AssigneeIntergalactic Therapeutics, Inc.
InventorsBruce C. Schnepp, Philip R. Johnson
Estimating the term…
Provided herein are isolated DNA vectors comprising a heterologous gene, wherein the DNA vector is devoid of bacterial plasmid DNA and/or bacterial signatures, which can abrogate persistence in vivo. The invention also features pharmaceutical compositions (non-immunogenic pharmaceutical compositions) including the DNA vectors of the invention, which can be used for induction of long-term, episomal expression of a heterologous gene in a subject. The invention involves methods of treating a subject by administering the DNA vectors of the invention, including methods of treating disorders associated with a defect in a target gene.
A method of expressing a polypeptide in a subject, the method comprising:
Dependencies are inferred from the claim text.